$5.86- $82.75 low to high. A muliple of 14.12. The same formula applied to NEU would be .98- $13.83.
It does happen, NEU is less than 6 degrees of separation from Baker Bros.
NEU could be working on a far more complex deal. ROW could well come not play from Japan and EU as well as a deal with ACAD or even BB.
With 3 Phase 2 trials starting this year, it’s a great time for creating wealth. NEU’s experience from Retts and FX trials would give us hope that these 3 trials would be even better outcomes having improved trial design.
It would be worth asking the company which Department of the FDA these 3 indications are administered by. My guess would be Neurology Dept. Retts was also Under Neurology as opposed to Psychology who handle FX. That’s why FX has gone cold.
We may even have news coming for FX, they have had the FX file for a lengthy amount of time. News of the path fwd should come at some stage.
NEU Price at posting:
$2.85 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)